Zhijing Yu

Associate
Full contact info

Experience

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Rowook Park
Partner, San Diego
Ruomu Li
Partner, Shanghai
Jenny Ge
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Sonia Nath
Partner, Washington, DC
Jean Park
Partner, New York
Lei Shen
Partner, Chicago
Elizabeth Anne Wright
Of Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Andrew Bae
Associate, Washington, DC
Julia R. Brinton
Associate, Washington, DC
Megan Drill
Associate, San Diego
Mari Dugas
Associate, Washington, DC
Allison Kutner
Associate, New York
Joyce Li
Associate, Chicago
Jiqiang Lin
Associate, New York
Tyler McClure
Associate, San Francisco
Patrick Sharma
Associate, Los Angeles Santa Monica
Ivy Wang
Associate, Shanghai
Monica Xu
Counsel, Shanghai
Freddy Yip
Associate, Hong Kong
Zhijing Yu
Associate, Singapore
Andy Zachrich
Associate, San Diego
Letian Wei
Legal Consultant, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries

SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb

December 11, 2023

Cooley advised SystImmune, a clinical-stage biopharmaceutical company, on its exclusive license and collaboration agreement with Bristol Myers Squibb for SystImmune’s BL-B01D1.

Read more

Related contacts

Kate Hillier
Partner, Seattle
Lila Hope
Partner, Palo Alto
Chen Chen
Partner, Boston
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Los Angeles Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
David D. Suh
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Andrew Epstein
Special Counsel, Seattle
Daniel Millard
Associate, London
Zhijing Yu
Associate, Singapore
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC

Related Practices & Industries

Agtech Startup eFishery Announces Series D Financing, Unicorn Status

July 11, 2023

Cooley advised eFishery, an Indonesia-based agtech startup, on its Series D financing raising $200 million, bringing its valuation to $1.4 billion.

Read more

Related contacts

Andrew Harline
Partner in Charge – Singapore, Singapore
Matthew Bartus
Partner, San Francisco
Tim Pitrelli
Partner, Singapore
Pearlynn Wang
Associate, Singapore
Shu-en Wee
Associate, Singapore
Yi Jia Ng
Associate, Singapore
Steven Holm
Associate, Singapore
Zhijing Yu
Associate, Singapore

Related Practices & Industries

Admissions & credentials

New York

Certified Information Privacy Professional/Asia (CIPP/ASIA)